The novel coronavirus is still in the spotlight, and with the covid 19 vaccines being so problematic for some individuals due to their potential side effects, treatments that turn out viable are really useful and precious these days.
Check out the latest reports about an antiviral combo.
Antiviral combo for covid 19
There are currently a number of different drugs at different stages of research evaluation to test their effectiveness against SARS-CoV-2, the virus that causes covid 19.
Part of these efforts is a research group from the University of Pennsylvania that has identified a combination of antiviral drugs to treat covid.
The blend includes an experimental drug called brequinar with the drugs remdesivir or molnupiravir, according to the latest reports revealed in Medical News Today.
It’s been also reported that researchers have tested this combination on both human respiratory cells and in mice.
“They believe the results they have seen show the drug combination has the potential to become a promising treatment for COVID-19.”
It’s been revealed that the results have been published in the scientific magazine Nature.
Check out more details about this in the original notes.
Covid experts search for a universal vaccine
It’s been just revealed that experts are chasing a universal covid vaccine. Check out the latest reports below.
Washington Post began a recent article by noting that the volunteers are rolling up their sleeves to receive shots of experimental vaccines tailored to beat the omicron variant — just as the winter coronavirus surge begins to relent.
The notes continued and revealed the following:
“By the time scientists know whether those rebooted vaccines are effective and safe, omicron is expected to be in the rearview mirror. Already, mask mandates are easing. People are beginning to talk about normalcy. The disconnect highlights the exhausting scientific chase of the last year — and the one that lies ahead.”
Stay tuned for more news.